Id |
Subject |
Object |
Predicate |
Lexical cue |
ForCovid19 |
Memo |
all_replicate |
tao:has_database_id |
T63 |
0-18 |
NegativeRegulation |
denotes |
Counter-regulatory |
|
|
t |
|
T25 |
19-45 |
Phenomena |
denotes |
'Renin-Angiotensin' System |
|
|
|
MESH:D012084 |
T26 |
62-67 |
Chemical |
denotes |
Drugs |
drug |
MESH:D008511 |
|
|
T91 |
71-76 |
Therapy |
denotes |
Treat |
|
|
|
|
T10 |
77-85 |
Disease |
denotes |
COVID-19 |
|
|
|
MESH:D000086382 |
T1 |
98-108 |
Species |
denotes |
SARS-CoV-2 |
|
|
t |
Tax:2697049 |
T28 |
109-117 |
Disease |
denotes |
infected |
|
|
t |
MESH:D007239 |
T31 |
118-126 |
Species |
denotes |
patients |
|
|
|
Tax:9606 |
T2 |
128-138 |
Species |
denotes |
SARS-CoV-2 |
|
|
|
Tax:2697049 |
T11 |
141-149 |
Disease |
denotes |
COVID-19 |
|
|
|
MESH:D000086382 |
T34 |
158-184 |
Phenomena |
denotes |
'Renin-Angiotensin' System |
|
|
|
MESH:D012084 |
T62 |
200-226 |
Phenomena |
denotes |
'Renin-Angiotensin' system |
|
|
|
MESH:D012084 |
T37 |
228-231 |
Phenomena |
denotes |
RAS |
|
|
|
MESH:D012084 |
T65 |
254-292 |
Phenomena |
denotes |
'Renin-Angiotensin-Aldosterone' system |
|
|
|
MESH:D012084 |
T81 |
332-338 |
Species |
denotes |
humans |
|
|
|
Tax:9606 |
T67 |
367-372 |
Anatomy |
denotes |
renal |
|
|
|
MESH:D007668 |
T70 |
374-388 |
Anatomy |
denotes |
cardiovascular |
|
MESH:D002319 |
|
|
T71 |
393-406 |
Phenomena |
denotes |
innate immune |
|
|
|
MESH:D007113 |
T89 |
459-468 |
Chemical |
denotes |
vitamin D |
|
|
|
MESH:D014807 |
T82 |
523-542 |
NegativeRegulation |
denotes |
negative regulatory |
|
|
|
|
T38 |
557-560 |
Phenomena |
denotes |
RAS |
|
|
|
MESH:D012084 |
T92 |
588-603 |
PositiveRegulation |
denotes |
over-reactivity |
|
|
|
|
T39 |
608-611 |
Phenomena |
denotes |
RAS |
|
|
|
MESH:D012084 |
T94 |
627-644 |
Disease |
denotes |
hypovitaminosis D |
|
|
|
MESH:D014808 |
T68 |
692-697 |
Anatomy |
denotes |
renal |
|
|
|
MESH:D007668 |
T83 |
699-706 |
Anatomy |
denotes |
cardiac |
|
MESH:D002319 |
|
|
T84 |
708-716 |
Anatomy |
denotes |
vascular |
|
MESH:D002319 |
|
|
T86 |
721-727 |
Phenomena |
denotes |
immune |
|
MESH:D007109 |
|
|
T12 |
763-771 |
Disease |
denotes |
COVID-19 |
|
|
t |
MESH:D000086382 |
T32 |
772-780 |
Species |
denotes |
patients |
|
|
|
Tax:9606 |
T87 |
796-810 |
Disease |
denotes |
cytokine storm |
|
|
|
MESH:D000080424 |
T131 |
839-845 |
Phenomena |
denotes |
immune |
|
MESH:D007109 |
|
|
T97 |
936-942 |
Condition |
denotes |
lethal |
|
|
|
|
T96 |
943-978 |
Disease |
denotes |
acute respiratory distress syndrome |
|
|
|
MESH:D012128 |
T3 |
997-1007 |
Species |
denotes |
SARS-CoV-2 |
|
|
|
Tax:2697049 |
T13 |
1039-1047 |
Disease |
denotes |
COVID-19 |
|
|
|
MESH:D000086382 |
T123 |
1071-1080 |
PositiveRegulation |
denotes |
interfere |
|
|
|
|
T40 |
1090-1093 |
Phenomena |
denotes |
RAS |
|
|
|
MESH:D012084 |
T100 |
1101-1112 |
Phenomena |
denotes |
interacting |
|
MESH:D053585 |
|
|
T98 |
1122-1144 |
Gene |
denotes |
spike (S) glycoprotein |
|
|
|
Gene:43740568 |
T110 |
1172-1203 |
Gene |
denotes |
Angiotensin-Converting Enzyme 2 |
|
|
|
Gene:59272 |
T101 |
1205-1209 |
Gene |
denotes |
ACE2 |
|
|
|
Gene:59272 |
T111 |
1236-1245 |
Localization |
denotes |
expressed |
|
|
|
|
T113 |
1264-1280 |
Anatomy |
denotes |
epithelial cells |
|
|
|
MESH:D004847 |
T114 |
1286-1299 |
Anatomy |
denotes |
blood vessels |
|
|
|
MESH:D001808 |
T115 |
1301-1305 |
Anatomy |
denotes |
lung |
|
|
|
MESH:D008168 |
T119 |
1307-1313 |
Anatomy |
denotes |
kidney |
|
|
|
MESH:D007668 |
T69 |
1315-1328 |
Anatomy |
denotes |
renal tubules |
|
MESH:D007684 |
|
|
T124 |
1331-1340 |
Anatomy |
denotes |
intestine |
|
|
|
MESH:D007422 |
T118 |
1346-1351 |
Anatomy |
denotes |
heart |
|
|
|
MESH:D006321 |
T302 |
1367-1375 |
Anatomy |
denotes |
cerebral |
|
|
|
MESH:D001921 |
T125 |
1376-1383 |
Anatomy |
denotes |
neurons |
|
|
|
MESH:D009474 |
T128 |
1388-1394 |
Anatomy |
denotes |
immune |
|
|
|
MESH:D008264 |
T133 |
1388-1404 |
Anatomy |
denotes |
immune monocytes |
|
|
|
MESH:D009000 |
T126 |
1405-1416 |
Anatomy |
denotes |
macrophages |
|
|
|
MESH:D008264 |
T4 |
1435-1445 |
Species |
denotes |
SARS-CoV-2 |
|
|
|
Tax:2697049 |
T14 |
1454-1462 |
Disease |
denotes |
COVID-19 |
|
|
|
MESH:D000086382 |
T134 |
1503-1515 |
Disease |
denotes |
hypertension |
|
|
|
MESH:D006973 |
T135 |
1517-1532 |
Disease |
denotes |
atherosclerosis |
|
|
|
MESH:D050197 |
T136 |
1534-1544 |
Disease |
denotes |
thrombosis |
|
|
|
MESH:D013927 |
T137 |
1546-1558 |
Disease |
denotes |
coagulopathy |
|
|
|
MESH:D001778 |
T138 |
1561-1569 |
Disease |
denotes |
diarrhea |
|
|
|
MESH:D003967 |
T139 |
1571-1579 |
Disease |
denotes |
glaucoma |
|
|
|
MESH:D005901 |
T140 |
1581-1588 |
Disease |
denotes |
anosmia |
|
|
|
MESH:D000857 |
T141 |
1590-1597 |
Disease |
denotes |
ageusia |
|
|
|
MESH:D000370 |
T142 |
1599-1611 |
Disease |
denotes |
skin lesions |
|
|
|
MESH:D012871 |
T143 |
1613-1623 |
Disease |
denotes |
dermatitis |
|
|
|
MESH:D003872 |
T144 |
1626-1679 |
Disease |
denotes |
autoimmune inflammation of the central nervous system |
|
|
|
MESH:D020278 |
T145 |
1685-1692 |
Disease |
denotes |
damages |
|
|
|
|
T116 |
1723-1727 |
Anatomy |
denotes |
lung |
|
|
|
MESH:D008168 |
T117 |
1729-1734 |
Anatomy |
denotes |
heart |
|
|
|
MESH:D006321 |
T120 |
1736-1742 |
Anatomy |
denotes |
kidney |
|
|
|
MESH:D007668 |
T146 |
1748-1756 |
Anatomy |
denotes |
testicle |
|
|
|
MESH:D013737 |
T315 |
1773-1778 |
Disease |
denotes |
these |
|
|
|
|
T147 |
1779-1786 |
Condition |
denotes |
diffuse |
|
|
|
|
T15 |
1787-1795 |
Disease |
denotes |
COVID-19 |
|
|
|
MESH:D000086382 |
T148 |
1830-1843 |
PositiveRegulation |
denotes |
over-reaction |
|
|
|
|
T41 |
1847-1850 |
Phenomena |
denotes |
RAS |
|
|
|
MESH:D012084 |
T5 |
1854-1864 |
Species |
denotes |
SARS-CoV-2 |
|
|
t |
Tax:2697049 |
T29 |
1865-1873 |
Disease |
denotes |
infected |
|
|
t |
MESH:D007239 |
T30 |
1874-1881 |
Species |
denotes |
persons |
|
|
|
Tax:9606 |
T42 |
1890-1893 |
Phenomena |
denotes |
RAS |
|
|
|
MESH:D012084 |
T149 |
1894-1903 |
PositiveRegulation |
denotes |
imbalance |
|
|
|
|
T95 |
1929-1946 |
Disease |
denotes |
hypovitaminosis D |
|
|
|
MESH:D014808 |
T43 |
1964-1967 |
Phenomena |
denotes |
RAS |
|
|
|
MESH:D012084 |
T16 |
1993-2001 |
Disease |
denotes |
COVID-19 |
|
|
|
MESH:D000086382 |
T44 |
2106-2109 |
Phenomena |
denotes |
RAS |
|
|
|
MESH:D012084 |
T17 |
2131-2139 |
Disease |
denotes |
COVID-19 |
|
|
|
MESH:D000086382 |
T35 |
2151-2177 |
Phenomena |
denotes |
'Renin-Angiotensin' System |
|
|
|
MESH:D012084 |
T36 |
2179-2182 |
Phenomena |
denotes |
RAS |
|
|
|
MESH:D012084 |
T64 |
2186-2204 |
NegativeRegulation |
denotes |
Counter-regulatory |
|
|
|
|
T45 |
2205-2208 |
Phenomena |
denotes |
RAS |
|
|
|
MESH:D012084 |
T46 |
2216-2219 |
Phenomena |
denotes |
RAS |
|
|
|
MESH:D012084 |
T150 |
2237-2242 |
Gene |
denotes |
Renin |
|
|
|
Gene:5972 |
T121 |
2244-2250 |
Anatomy |
denotes |
kidney |
|
|
|
MESH:D007668 |
T170 |
2252-2259 |
PositiveRegulation |
denotes |
cleaves |
|
|
|
|
T151 |
2260-2275 |
Gene |
denotes |
Angiotensinogen |
|
|
|
Gene:183 |
T122 |
2277-2282 |
Anatomy |
denotes |
liver |
|
|
|
MESH:D008099 |
T152 |
2292-2305 |
Biological |
denotes |
Angiotensin I |
|
|
|
MESH:D000803 |
T166 |
2320-2330 |
Biological |
denotes |
DRVYIHPFHL |
|
|
|
MESH:D010455 |
T184 |
2337-2343 |
Biological |
denotes |
latter |
|
|
|
MESH:D000803 |
T185 |
2347-2354 |
PositiveRegulation |
denotes |
cleaved |
|
|
|
|
T173 |
2362-2391 |
Gene |
denotes |
Angiotensin-Converting Enzyme |
|
|
|
Gene:1636 |
T174 |
2393-2396 |
Gene |
denotes |
ACE |
|
|
|
Gene:1636 |
T153 |
2409-2423 |
Gene |
denotes |
Angiotensin II |
|
|
|
MESH:D000804 |
T167 |
2438-2446 |
Biological |
denotes |
DRVYIHPF |
|
|
|
MESH:D010455 |
T102 |
2475-2479 |
Gene |
denotes |
ACE2 |
|
|
|
Gene:59272 |
T6 |
2481-2500 |
Gene |
denotes |
SARS-CoV-2 receptor |
|
|
|
Gene:59272 |
T47 |
2524-2527 |
Phenomena |
denotes |
RAS |
|
|
|
MESH:D012084 |
T196 |
2542-2549 |
Phenomena |
denotes |
targets |
|
MESH:D011485 |
|
|
T154 |
2553-2567 |
Biological |
denotes |
Angiotensin II |
|
|
|
MESH:D000804 |
T326 |
2576-2591 |
Phenomena |
denotes |
vasoconstrictor |
|
|
|
MESH:D014661 |
T214 |
2592-2598 |
Gene |
denotes |
type 1 |
|
|
|
Gene:185 |
T198 |
2600-2604 |
Gene |
denotes |
AT1R |
|
|
|
Gene:185 |
T321 |
2610-2623 |
Phenomena |
denotes |
vasodilatator |
|
|
|
MESH:D014664 |
T217 |
2624-2630 |
Gene |
denotes |
type 2 |
|
|
|
Gene:186 |
T202 |
2632-2636 |
Gene |
denotes |
AT2R |
|
|
|
Gene:186 |
T216 |
2638-2661 |
Gene |
denotes |
Angiotensin II receptor |
|
|
|
Gene:186 |
T155 |
2638-2661 |
Gene |
denotes |
Angiotensin II receptor |
|
|
|
Gene:185 |
T199 |
2664-2668 |
Gene |
denotes |
AT1R |
|
|
|
Gene:185 |
T112 |
2672-2681 |
Localization |
denotes |
expressed |
|
|
|
|
T218 |
2700-2709 |
Anatomy |
denotes |
monocytes |
|
|
|
MESH:D009000 |
T127 |
2710-2721 |
Anatomy |
denotes |
macrophages |
|
|
|
MESH:D008264 |
T219 |
2726-2733 |
Anatomy |
denotes |
T-cells |
|
|
|
MESH:D013601 |
T48 |
2750-2753 |
Phenomena |
denotes |
RAS |
|
|
|
MESH:D012084 |
T319 |
2754-2758 |
PositiveRegulation |
denotes |
acts |
|
|
|
|
T320 |
2762-2777 |
Phenomena |
denotes |
innate immunity |
|
|
|
MESH:D007113 |
T186 |
2793-2800 |
PositiveRegulation |
denotes |
cleaved |
|
|
|
|
T103 |
2804-2808 |
Gene |
denotes |
ACE2 |
|
|
|
Gene:59272 |
T156 |
2810-2824 |
Biological |
denotes |
Angiotensin II |
|
|
|
MESH:D000804 |
T190 |
2831-2846 |
Biological |
denotes |
Angiotensin 1-7 |
|
|
|
MESH:C118790 |
T195 |
2861-2868 |
Biological |
denotes |
DRVYIHP |
|
|
|
MESH:D010455 |
T221 |
2871-2880 |
Phenomena |
denotes |
targeting |
|
MESH:D011485 |
|
|
T322 |
2885-2898 |
Phenomena |
denotes |
vasodilatator |
|
|
|
MESH:D014664 |
T327 |
2899-2926 |
Gene |
denotes |
proto-oncogene Mas receptor |
|
|
|
Gene:116511 |
T220 |
2928-2932 |
Gene |
denotes |
MasR |
|
|
|
Gene:116511 |
T191 |
2935-2950 |
Biological |
denotes |
Angiotensin 1-7 |
|
|
|
MESH:C118790 |
T223 |
2966-2977 |
PositiveRegulation |
denotes |
transformed |
|
|
|
|
T222 |
2981-2991 |
Biological |
denotes |
Alamandine |
|
|
|
MESH:C581752 |
T213 |
3006-3013 |
Biological |
denotes |
ARVYIHP |
|
|
|
MESH:D010455 |
T224 |
3021-3044 |
Gene |
denotes |
aspartate decarboxylase |
|
|
|
MESH:C019747 |
T228 |
3046-3056 |
Biological |
denotes |
Alamandine |
|
|
|
MESH:C581752 |
T229 |
3063-3067 |
Phenomena |
denotes |
bind |
|
MESH:D011485 |
|
|
T323 |
3075-3088 |
Phenomena |
denotes |
vasodilatator |
|
|
|
MESH:D014664 |
T225 |
3089-3136 |
Gene |
denotes |
Mas-related G protein-coupled receptor member D |
|
|
|
Gene:116512 |
T226 |
3138-3142 |
Gene |
denotes |
MRGD |
|
|
|
Gene:116512 |
T192 |
3171-3186 |
Biological |
denotes |
Angiotensin 1-7 |
|
|
|
MESH:C118790 |
T157 |
3201-3215 |
Biological |
denotes |
Angiotensin II |
|
|
|
MESH:D000804 |
T231 |
3220-3227 |
PositiveRegulation |
denotes |
produce |
|
|
|
|
T328 |
3228-3241 |
Biological |
denotes |
Angiotensin A |
|
|
|
MESH:C516880 |
T230 |
3228-3241 |
Biological |
denotes |
Angiotensin A |
|
|
|
MESH:C516880 |
T329 |
3256-3264 |
Biological |
denotes |
ARVYIHPF |
|
|
|
MESH:D010455 |
T209 |
3256-3264 |
Biological |
denotes |
ARVYIHPF |
|
|
|
MESH:D010455 |
T232 |
3273-3296 |
Gene |
denotes |
aspartate decarboxylase |
|
|
|
MESH:C019747 |
T234 |
3302-3312 |
Biological |
denotes |
Alamandine |
|
|
|
MESH:C581752 |
T104 |
3331-3335 |
Gene |
denotes |
ACE2 |
|
|
|
Gene:59272 |
T233 |
3336-3344 |
PositiveRegulation |
denotes |
cleavage |
|
|
|
|
T105 |
3346-3350 |
Gene |
denotes |
ACE2 |
|
|
|
Gene:59272 |
T236 |
3360-3366 |
PositiveRegulation |
denotes |
cleave |
|
|
|
|
T158 |
3367-3380 |
Biological |
denotes |
Angiotensin I |
|
|
|
MESH:D000803 |
T235 |
3389-3404 |
Biological |
denotes |
Angiotensin 1-9 |
|
|
|
MESH:C506331 |
T169 |
3419-3428 |
Biological |
denotes |
DRVYIHPFH |
|
|
|
MESH:D010455 |
T197 |
3437-3444 |
Phenomena |
denotes |
targets |
|
MESH:D011485 |
|
|
T203 |
3445-3449 |
Gene |
denotes |
AT2R |
|
|
|
Gene:186 |
T49 |
3458-3461 |
Phenomena |
denotes |
RAS |
|
|
|
MESH:D012084 |
T159 |
3505-3520 |
Biological |
denotes |
Angiotensin III |
|
|
|
MESH:D000805 |
T206 |
3535-3542 |
Biological |
denotes |
RVYIHPF |
|
|
|
MESH:D010455 |
T160 |
3548-3562 |
Biological |
denotes |
Angiotensin IV |
|
|
|
MESH:C022929 |
T210 |
3577-3583 |
Biological |
denotes |
VYIHPF |
|
|
|
MESH:D010455 |
T239 |
3594-3603 |
Phenomena |
denotes |
targeting |
|
MESH:D011485 |
|
|
T237 |
3594-3603 |
Phenomena |
denotes |
targeting |
|
MESH:D011485 |
|
|
T200 |
3608-3612 |
Gene |
denotes |
AT1R |
|
|
|
Gene:185 |
T324 |
3617-3630 |
Phenomena |
denotes |
vasodilatator |
|
|
|
MESH:D014664 |
T238 |
3631-3635 |
Gene |
denotes |
AT4R |
|
alternative short name: IRAP |
|
Gene:4012 |
T50 |
3695-3698 |
Phenomena |
denotes |
RAS |
|
|
|
MESH:D012084 |
T247 |
3700-3711 |
Biological |
denotes |
Angiotensin |
|
|
|
MESH:D000804 |
T243 |
3700-3711 |
Biological |
denotes |
Angiotensin |
|
|
|
MESH:D000803 |
T241 |
3713-3714 |
Biological |
denotes |
I |
|
|
|
MESH:D000803 |
T245 |
3719-3721 |
Biological |
denotes |
II |
|
|
|
MESH:D000804 |
T161 |
3729-3744 |
Biological |
denotes |
Angiotensin III |
|
|
|
MESH:D000805 |
T51 |
3791-3794 |
Phenomena |
denotes |
RAS |
|
|
|
MESH:D012084 |
T18 |
3833-3841 |
Disease |
denotes |
COVID-19 |
|
|
|
MESH:D000086382 |
T78 |
3884-3904 |
NegativeRegulation |
denotes |
'counter-regulatory' |
|
|
|
|
T52 |
3905-3908 |
Phenomena |
denotes |
RAS |
|
|
|
MESH:D012084 |
T262 |
3939-3950 |
Phenomena |
denotes |
homeostasis |
|
|
|
MESH:D006706 |
T193 |
3965-3980 |
Biological |
denotes |
Angiotensin 1-7 |
|
|
|
MESH:C118790 |
T248 |
3982-3997 |
Biological |
denotes |
Angiotensin 1-9 |
|
|
|
MESH:C506331 |
T251 |
3999-4009 |
Biological |
denotes |
Alamandine |
|
|
|
MESH:C581752 |
T252 |
4011-4024 |
Biological |
denotes |
Angiotensin A |
|
|
|
MESH:C516880 |
T162 |
4030-4044 |
Biological |
denotes |
Angiotensin IV |
|
|
|
MESH:C022929 |
T261 |
4056-4065 |
Phenomena |
denotes |
targeting |
|
MESH:D011485 |
|
|
T260 |
4056-4065 |
Phenomena |
denotes |
targeting |
|
MESH:D011485 |
|
|
T259 |
4056-4065 |
Phenomena |
denotes |
targeting |
|
MESH:D011485 |
|
|
T258 |
4056-4065 |
Phenomena |
denotes |
targeting |
|
MESH:D011485 |
|
|
T254 |
4056-4065 |
Phenomena |
denotes |
targeting |
|
MESH:D011485 |
|
|
T255 |
4070-4074 |
Gene |
denotes |
MasR |
|
|
|
Gene:116511 |
T204 |
4076-4080 |
Gene |
denotes |
AT2R |
|
|
|
Gene:186 |
T256 |
4082-4086 |
Gene |
denotes |
MRGD |
|
|
|
Gene:116512 |
T106 |
4088-4092 |
Gene |
denotes |
ACE2 |
|
|
|
Gene:59272 |
T257 |
4097-4101 |
Gene |
denotes |
AT4R |
|
alternative short name: IRAP |
|
Gene:4012 |
T325 |
4102-4115 |
Phenomena |
denotes |
vasodilatator |
|
|
|
MESH:D014664 |
T263 |
4141-4155 |
Biological |
denotes |
These peptides |
|
|
|
MESH:D010455 |
T264 |
4178-4194 |
Phenomena |
denotes |
cardioprotective |
|
|
|
|
T265 |
4196-4206 |
Phenomena |
denotes |
vasoactive |
|
|
|
|
T266 |
4208-4225 |
Phenomena |
denotes |
anti-hypertensive |
|
|
|
|
T267 |
4228-4245 |
Phenomena |
denotes |
anti-hypertrophic |
|
|
|
|
T268 |
4253-4270 |
Phenomena |
denotes |
anti-inflammatory |
|
|
|
|
T189 |
4288-4321 |
Biological |
denotes |
Such naturally-produced molecules |
|
|
|
MESH:D010455 |
T53 |
4329-4332 |
Phenomena |
denotes |
RAS |
|
|
|
MESH:D012084 |
T269 |
4349-4359 |
NegativeRegulation |
denotes |
counteract |
|
|
|
|
T7 |
4364-4374 |
Species |
denotes |
SARS-CoV-2 |
|
|
|
Tax:2697049 |
T270 |
4383-4398 |
PositiveRegulation |
denotes |
over-activation |
|
|
|
|
T54 |
4402-4405 |
Phenomena |
denotes |
RAS |
|
|
|
MESH:D012084 |
T271 |
4410-4417 |
NegativeRegulation |
denotes |
reverse |
|
|
|
|
T19 |
4450-4458 |
Disease |
denotes |
COVID-19 |
|
|
|
MESH:D000086382 |
T55 |
4518-4532 |
Chemical |
denotes |
RAS inhibitors |
drug |
|
|
|
T20 |
4593-4601 |
Disease |
denotes |
COVID-19 |
|
|
|
MESH:D000086382 |
T33 |
4602-4610 |
Species |
denotes |
patients |
|
|
|
Tax:9606 |
T56 |
4632-4644 |
Chemical |
denotes |
RAS blockers |
drug |
|
|
|
T21 |
4668-4676 |
Disease |
denotes |
COVID-19 |
|
|
|
MESH:D000086382 |
T57 |
4711-4725 |
Chemical |
denotes |
RAS inhibitors |
drug |
|
|
|
T316 |
4733-4740 |
Inhibition |
denotes |
prevent |
|
|
|
|
T88 |
4745-4759 |
Disease |
denotes |
cytokine storm |
|
|
|
MESH:D000080424 |
T58 |
4763-4766 |
Phenomena |
denotes |
RAS |
|
|
|
MESH:D012084 |
T274 |
4794-4801 |
PositiveRegulation |
denotes |
release |
|
|
|
|
T318 |
4805-4821 |
Type |
denotes |
pro-inflammatory |
|
|
|
|
T273 |
4822-4831 |
Biological |
denotes |
cytokines |
|
|
|
MESH:D016207 |
T22 |
4856-4864 |
Disease |
denotes |
COVID-19 |
|
|
|
MESH:D000086382 |
T8 |
4878-4888 |
Species |
denotes |
SARS-CoV-2 |
|
|
|
Tax:2697049 |
T27 |
4889-4897 |
Disease |
denotes |
infected |
|
|
|
MESH:D007239 |
T80 |
4898-4904 |
Species |
denotes |
humans |
|
|
|
Tax:9606 |
T59 |
4919-4922 |
Phenomena |
denotes |
RAS |
|
|
|
MESH:D012084 |
T276 |
4923-4935 |
PositiveRegulation |
denotes |
over-reacted |
|
|
|
|
T107 |
4944-4948 |
Gene |
denotes |
ACE2 |
|
|
|
Gene:59272 |
T277 |
4960-4965 |
Species |
denotes |
viral |
|
|
|
Tax:2697049 |
T279 |
4966-4975 |
Disease |
denotes |
infection |
|
|
|
MESH:D007239 |
T90 |
4980-5000 |
Disease |
denotes |
vitamin D deficiency |
|
|
|
http://purl.obolibrary.org/obo/HP_0100512 |
T23 |
5027-5035 |
Disease |
denotes |
COVID-19 |
|
|
|
MESH:D000086382 |
T60 |
5065-5068 |
Phenomena |
denotes |
RAS |
|
|
|
MESH:D012084 |
T280 |
5094-5116 |
Chemical |
denotes |
chemotherapeutic drugs |
drug |
|
|
|
T289 |
5122-5140 |
Chemical |
denotes |
proposed molecules |
|
|
|
|
T182 |
5154-5168 |
Chemical |
denotes |
ACE inhibitors |
drug |
|
|
|
T282 |
5173-5180 |
Inhibition |
denotes |
prevent |
|
|
|
|
T281 |
5185-5195 |
PositiveRegulation |
denotes |
production |
|
|
|
|
T163 |
5199-5213 |
Biological |
denotes |
Angiotensin II |
|
|
|
MESH:D000804 |
T164 |
5219-5232 |
Biological |
denotes |
Angiotensin I |
|
|
|
MESH:D000803 |
T283 |
5239-5247 |
Chemical |
denotes |
blockers |
drug |
|
|
|
T284 |
5248-5259 |
Chemical |
denotes |
antagonists |
drug |
|
|
|
T201 |
5263-5267 |
Gene |
denotes |
AT1R |
|
|
|
Gene:185 |
T286 |
5276-5284 |
Chemical |
denotes |
Losartan |
drug |
|
|
|
T285 |
5276-5284 |
Chemical |
denotes |
Losartan |
drug |
|
|
MESH:D019808 |
T288 |
5289-5300 |
Chemical |
denotes |
derivatives |
drug |
|
|
|
T290 |
5302-5313 |
Type |
denotes |
Recombinant |
|
|
|
MESH:D011994 |
T108 |
5314-5318 |
Gene |
denotes |
ACE2 |
|
|
|
Gene:59272 |
T292 |
5397-5408 |
NegativeRegulation |
denotes |
competitive |
|
|
|
|
T291 |
5409-5416 |
Phenomena |
denotes |
binding |
|
|
|
MESH:D011485 |
T99 |
5424-5446 |
Gene |
denotes |
spike (S) glycoprotein |
|
|
|
Gene:43740568 |
T9 |
5450-5460 |
Species |
denotes |
SARS-CoV-2 |
|
|
|
Tax:2697049 |
T293 |
5510-5523 |
Chemical |
denotes |
peptide drugs |
drug |
|
|
MESH:D010455 |
T79 |
5543-5563 |
NegativeRegulation |
denotes |
'counter-regulatory' |
|
|
|
|
T61 |
5564-5567 |
Phenomena |
denotes |
RAS |
|
|
|
MESH:D012084 |
T194 |
5574-5589 |
Biological |
denotes |
Angiotensin 1-7 |
|
|
|
MESH:C118790 |
T249 |
5591-5606 |
Biological |
denotes |
Angiotensin 1-9 |
|
|
|
MESH:C506331 |
T250 |
5608-5618 |
Biological |
denotes |
Alamandine |
|
|
|
MESH:C581752 |
T253 |
5620-5633 |
Biological |
denotes |
Angiotensin A |
|
|
|
MESH:C516880 |
T165 |
5641-5655 |
Biological |
denotes |
Angiotensin IV |
|
|
|
MESH:C022929 |
T24 |
5665-5673 |
Disease |
denotes |
COVID-19 |
|
|
|
MESH:D000086382 |
T301 |
5689-5697 |
Phenomena |
denotes |
targeted |
|
MESH:D011485 |
|
|
T300 |
5689-5697 |
Phenomena |
denotes |
targeted |
|
MESH:D011485 |
|
|
T299 |
5689-5697 |
Phenomena |
denotes |
targeted |
|
MESH:D011485 |
|
|
T298 |
5689-5697 |
Phenomena |
denotes |
targeted |
|
MESH:D011485 |
|
|
T297 |
5689-5697 |
Phenomena |
denotes |
targeted |
|
MESH:D011485 |
|
|
T294 |
5722-5726 |
Gene |
denotes |
MasR |
|
|
|
Gene:116511 |
T205 |
5728-5732 |
Gene |
denotes |
AT2R |
|
|
|
Gene:186 |
T295 |
5734-5738 |
Gene |
denotes |
MRGD |
|
|
|
Gene:116512 |
T109 |
5740-5744 |
Gene |
denotes |
ACE2 |
|
|
|
Gene:59272 |
T296 |
5749-5753 |
Gene |
denotes |
AT4R |
|
alternative short name: IRAP |
|
Gene:4012 |
R100 |
T184 |
T152 |
coreference |
latter,Angiotensin I |
R101 |
T184 |
T185 |
is_a |
latter,cleaved |
R102 |
T151 |
T170 |
is_a |
Angiotensinogen,cleaves |
R103 |
T170 |
T152 |
is_a |
cleaves,Angiotensin I |
R104 |
T170 |
T166 |
is_a |
cleaves,DRVYIHPFHL |
R105 |
T185 |
T153 |
is_a |
cleaved,Angiotensin II |
R106 |
T185 |
T167 |
is_a |
cleaved,DRVYIHPF |
R107 |
T173 |
T185 |
using |
Angiotensin-Converting Enzyme,cleaved |
R108 |
T156 |
T186 |
is_a |
Angiotensin II,cleaved |
R109 |
T186 |
T190 |
is_a |
cleaved,Angiotensin 1-7 |
R110 |
T103 |
T186 |
using |
ACE2,cleaved |
R111 |
T186 |
T195 |
is_a |
cleaved,DRVYIHP |
R112 |
T214 |
T155 |
- |
type 1,Angiotensin II receptor |
R113 |
T217 |
T216 |
- |
type 2,Angiotensin II receptor |
R115 |
T196 |
T214 |
to |
targets,type 1 |
R116 |
T196 |
T217 |
to |
targets,type 2 |
R117 |
T198 |
T214 |
abbreviation |
AT1R,type 1 |
R118 |
T202 |
T217 |
abbreviation |
AT2R,type 2 |
R119 |
T199 |
T112 |
is_a |
AT1R,expressed |
R123 |
T190 |
T221 |
is_a |
Angiotensin 1-7,targeting |
R125 |
T191 |
T223 |
is_a |
Angiotensin 1-7,transformed |
R126 |
T223 |
T222 |
is_a |
transformed,Alamandine |
R127 |
T223 |
T213 |
is_a |
transformed,ARVYIHP |
R128 |
T224 |
T223 |
using |
aspartate decarboxylase,transformed |
R129 |
T226 |
T225 |
abbreviation |
MRGD,Mas-related G protein-coupled receptor member D |
R131 |
T229 |
T225 |
to |
bind,Mas-related G protein-coupled receptor member D |
R132 |
T157 |
T231 |
is_a |
Angiotensin II,produce |
R133 |
T231 |
T230 |
is_a |
produce,Angiotensin A |
R134 |
T231 |
T209 |
is_a |
produce,ARVYIHPF |
R135 |
T232 |
T231 |
using |
aspartate decarboxylase,produce |
R137 |
T233 |
T234 |
is_a |
cleavage,Alamandine |
R139 |
T158 |
T236 |
is_a |
Angiotensin I,cleave |
R14 |
T5 |
T29 |
cause_of |
SARS-CoV-2,infected |
R140 |
T236 |
T235 |
is_a |
cleave,Angiotensin 1-9 |
R141 |
T105 |
T236 |
using |
ACE2,cleave |
R142 |
T236 |
T169 |
is_a |
cleave,DRVYIHPFH |
R143 |
T235 |
T197 |
is_a |
Angiotensin 1-9,targets |
R145 |
T159 |
T237 |
is_a |
Angiotensin III,targeting |
R146 |
T206 |
T237 |
is_a |
RVYIHPF,targeting |
R147 |
T237 |
T200 |
to |
targeting,AT1R |
R148 |
T160 |
T239 |
is_a |
Angiotensin IV,targeting |
R149 |
T210 |
T239 |
is_a |
VYIHPF,targeting |
R150 |
T239 |
T238 |
to |
targeting,AT4R |
R151 |
T243 |
T241 |
- |
Angiotensin,I |
R152 |
T247 |
T245 |
- |
Angiotensin,II |
R153 |
T193 |
T254 |
is_a |
Angiotensin 1-7,targeting |
R154 |
T254 |
T255 |
to |
targeting,MasR |
R155 |
T197 |
T203 |
to |
targets,AT2R |
R156 |
T248 |
T258 |
is_a |
Angiotensin 1-9,targeting |
R157 |
T258 |
T204 |
to |
targeting,AT2R |
R158 |
T251 |
T259 |
is_a |
Alamandine,targeting |
R159 |
T259 |
T256 |
to |
targeting,MRGD |
R16 |
T64 |
T45 |
is_a |
Counter-regulatory,RAS |
R160 |
T252 |
T260 |
is_a |
Angiotensin A,targeting |
R161 |
T260 |
T106 |
to |
targeting,ACE2 |
R162 |
T162 |
T261 |
is_a |
Angiotensin IV,targeting |
R163 |
T261 |
T257 |
to |
targeting,AT4R |
R164 |
T263 |
T193 |
coreference |
These peptides,Angiotensin 1-7 |
R165 |
T263 |
T248 |
coreference |
These peptides,Angiotensin 1-9 |
R166 |
T263 |
T251 |
coreference |
These peptides,Alamandine |
R167 |
T263 |
T252 |
coreference |
These peptides,Angiotensin A |
R168 |
T263 |
T162 |
coreference |
These peptides,Angiotensin IV |
R169 |
T263 |
T264 |
is_a |
These peptides,cardioprotective |
R17 |
T78 |
T52 |
is_a |
'counter-regulatory',RAS |
R170 |
T263 |
T265 |
is_a |
These peptides,vasoactive |
R171 |
T263 |
T266 |
is_a |
These peptides,anti-hypertensive |
R172 |
T263 |
T267 |
is_a |
These peptides,anti-hypertrophic |
R173 |
T263 |
T268 |
is_a |
These peptides,anti-inflammatory |
R175 |
T189 |
T263 |
coreference |
Such naturally-produced molecules,These peptides |
R176 |
T189 |
T269 |
is_a |
Such naturally-produced molecules,counteract |
R177 |
T269 |
T270 |
is_a |
counteract,over-activation |
R178 |
T270 |
T54 |
is_a |
over-activation,RAS |
R179 |
T53 |
T189 |
of_a |
RAS,Such naturally-produced molecules |
R180 |
T189 |
T271 |
is_a |
Such naturally-produced molecules,reverse |
R181 |
T7 |
T270 |
cause_of |
SARS-CoV-2,over-activation |
R184 |
T274 |
T273 |
is_a |
release,cytokines |
R185 |
T274 |
T88 |
cause_of |
release,cytokine storm |
R186 |
T277 |
T279 |
cause_of |
viral,infection |
R187 |
T277 |
T8 |
coreference |
viral,SARS-CoV-2 |
R188 |
T279 |
T276 |
is_a |
infection,over-reacted |
R189 |
T90 |
T276 |
is_a |
vitamin D deficiency,over-reacted |
R19 |
T8 |
T27 |
cause_of |
SARS-CoV-2,infected |
R190 |
T276 |
T59 |
is_a |
over-reacted,RAS |
R191 |
T276 |
T22 |
cause_of |
over-reacted,COVID-19 |
R192 |
T107 |
T279 |
via |
ACE2,infection |
R193 |
T164 |
T281 |
is_a |
Angiotensin I,production |
R194 |
T281 |
T163 |
is_a |
production,Angiotensin II |
R195 |
T282 |
T281 |
against |
prevent,production |
R196 |
T182 |
T282 |
has_role |
ACE inhibitors,prevent |
R197 |
T286 |
T288 |
- |
Losartan,derivatives |
R198 |
T289 |
T280 |
coreference |
proposed molecules,chemotherapeutic drugs |
R206 |
T290 |
T108 |
of_a |
Recombinant,ACE2 |
R21 |
T79 |
T61 |
is_a |
'counter-regulatory',RAS |
R210 |
T9 |
T99 |
of_a |
SARS-CoV-2,spike (S) glycoprotein |
R217 |
T194 |
T297 |
is_a |
Angiotensin 1-7,targeted |
R218 |
T297 |
T294 |
to |
targeted,MasR |
R219 |
T249 |
T298 |
is_a |
Angiotensin 1-9,targeted |
R220 |
T298 |
T205 |
to |
targeted,AT2R |
R221 |
T250 |
T299 |
is_a |
Alamandine,targeted |
R222 |
T299 |
T295 |
to |
targeted,MRGD |
R223 |
T253 |
T300 |
is_a |
Angiotensin A,targeted |
R224 |
T300 |
T109 |
to |
targeted,ACE2 |
R225 |
T301 |
T296 |
to |
targeted,AT4R |
R226 |
T165 |
T301 |
is_a |
Angiotensin IV,targeted |
R227 |
T302 |
T125 |
in |
cerebral,neurons |
R238 |
T3 |
T98 |
of_a |
SARS-CoV-2,spike (S) glycoprotein |
R242 |
T315 |
T134 |
coreference |
these,hypertension |
R243 |
T315 |
T135 |
coreference |
these,atherosclerosis |
R244 |
T315 |
T136 |
coreference |
these,thrombosis |
R245 |
T315 |
T137 |
coreference |
these,coagulopathy |
R246 |
T315 |
T138 |
coreference |
these,diarrhea |
R247 |
T315 |
T139 |
coreference |
these,glaucoma |
R248 |
T315 |
T140 |
coreference |
these,anosmia |
R249 |
T315 |
T141 |
coreference |
these,ageusia |
R25 |
T26 |
T91 |
using |
Drugs,Treat |
R250 |
T315 |
T142 |
coreference |
these,skin lesions |
R251 |
T315 |
T143 |
coreference |
these,dermatitis |
R252 |
T315 |
T144 |
coreference |
these,autoimmune inflammation of the central nervous system |
R253 |
T315 |
T145 |
coreference |
these,damages |
R254 |
T58 |
T274 |
is_a |
RAS,release |
R255 |
T57 |
T316 |
has_role |
RAS inhibitors,prevent |
R257 |
T316 |
T274 |
against |
prevent,release |
R258 |
T110 |
T111 |
is_a |
Angiotensin-Converting Enzyme 2,expressed |
R259 |
T318 |
T273 |
of_a |
pro-inflammatory,cytokines |
R261 |
T290 |
T292 |
is_a |
Recombinant,competitive |
R262 |
T292 |
T291 |
is_a |
competitive,binding |
R263 |
T291 |
T108 |
to |
binding,ACE2 |
R264 |
T99 |
T291 |
is_a |
spike (S) glycoprotein,binding |
R265 |
T48 |
T319 |
is_a |
RAS,acts |
R266 |
T319 |
T320 |
is_a |
acts,innate immunity |
R267 |
T217 |
T321 |
is_a |
type 2,vasodilatator |
R269 |
T225 |
T323 |
is_a |
Mas-related G protein-coupled receptor member D,vasodilatator |
R270 |
T238 |
T324 |
is_a |
AT4R,vasodilatator |
R271 |
T214 |
T326 |
is_a |
type 1,vasoconstrictor |
R272 |
T255 |
T325 |
is_a |
MasR,vasodilatator |
R273 |
T204 |
T325 |
is_a |
AT2R,vasodilatator |
R274 |
T256 |
T325 |
is_a |
MRGD,vasodilatator |
R275 |
T257 |
T325 |
is_a |
AT4R,vasodilatator |
R276 |
T220 |
T327 |
abbreviation |
MasR,proto-oncogene Mas receptor |
R277 |
T327 |
T322 |
is_a |
proto-oncogene Mas receptor,vasodilatator |
R278 |
T221 |
T327 |
to |
targeting,proto-oncogene Mas receptor |
R279 |
T104 |
T233 |
using |
ACE2,cleavage |
R28 |
T89 |
T82 |
is_a |
vitamin D,negative regulatory |
R280 |
T271 |
T19 |
is_a |
reverse,COVID-19 |
R281 |
T26 |
T25 |
for |
Drugs,'Renin-Angiotensin' System |
R282 |
T91 |
T10 |
for |
Treat,COVID-19 |
R283 |
T31 |
T10 |
has_a |
patients,COVID-19 |
R284 |
T31 |
T28 |
has_a |
patients,infected |
R285 |
T32 |
T12 |
has_a |
patients,COVID-19 |
R286 |
T32 |
T87 |
has_a |
patients,cytokine storm |
R287 |
T32 |
T96 |
has_a |
patients,acute respiratory distress syndrome |
R288 |
T111 |
T113 |
on |
expressed,epithelial cells |
R289 |
T111 |
T125 |
on |
expressed,neurons |
R29 |
T82 |
T38 |
is_a |
negative regulatory,RAS |
R290 |
T111 |
T133 |
on |
expressed,immune monocytes |
R291 |
T111 |
T128 |
on |
expressed,immune |
R292 |
T14 |
T136 |
is_a |
COVID-19,thrombosis |
R293 |
T14 |
T135 |
is_a |
COVID-19,atherosclerosis |
R294 |
T14 |
T134 |
is_a |
COVID-19,hypertension |
R295 |
T14 |
T143 |
is_a |
COVID-19,dermatitis |
R296 |
T14 |
T142 |
is_a |
COVID-19,skin lesions |
R297 |
T14 |
T141 |
is_a |
COVID-19,ageusia |
R298 |
T14 |
T139 |
is_a |
COVID-19,glaucoma |
R299 |
T14 |
T138 |
is_a |
COVID-19,diarrhea |
R3 |
T1 |
T28 |
cause_of |
SARS-CoV-2,infected |
R300 |
T14 |
T137 |
is_a |
COVID-19,coagulopathy |
R301 |
T14 |
T140 |
is_a |
COVID-19,anosmia |
R302 |
T14 |
T144 |
is_a |
COVID-19,autoimmune inflammation of the central nervous system |
R303 |
T14 |
T145 |
is_a |
COVID-19,damages |
R304 |
T145 |
T116 |
to |
damages,lung |
R305 |
T145 |
T117 |
to |
damages,heart |
R306 |
T145 |
T120 |
to |
damages,kidney |
R307 |
T145 |
T146 |
to |
damages,testicle |
R308 |
T15 |
T315 |
is_a |
COVID-19,these |
R309 |
T30 |
T29 |
has_a |
persons,infected |
R31 |
T92 |
T39 |
is_a |
over-reactivity,RAS |
R310 |
T30 |
T41 |
of_a |
persons,RAS |
R311 |
T148 |
T147 |
cause_of |
over-reaction,diffuse |
R312 |
T95 |
T149 |
is_a |
hypovitaminosis D,imbalance |
R313 |
T112 |
T218 |
on |
expressed,monocytes |
R314 |
T112 |
T127 |
on |
expressed,macrophages |
R315 |
T112 |
T219 |
on |
expressed,T-cells |
R316 |
T328 |
T233 |
is_a |
Angiotensin A,cleavage |
R317 |
T329 |
T233 |
is_a |
ARVYIHPF,cleavage |
R318 |
T169 |
T197 |
is_a |
DRVYIHPFH,targets |
R319 |
T222 |
T229 |
is_a |
Alamandine,bind |
R320 |
T195 |
T221 |
is_a |
DRVYIHP,targeting |
R321 |
T153 |
T196 |
is_a |
Angiotensin II,targets |
R322 |
T167 |
T196 |
is_a |
DRVYIHPF,targets |
R323 |
T33 |
T20 |
has_a |
patients,COVID-19 |
R324 |
T80 |
T27 |
has_a |
humans,infected |
R325 |
T80 |
T22 |
has_a |
humans,COVID-19 |
R326 |
T289 |
T182 |
is_a |
proposed molecules,ACE inhibitors |
R327 |
T289 |
T283 |
is_a |
proposed molecules,blockers |
R328 |
T289 |
T284 |
is_a |
proposed molecules,antagonists |
R329 |
T283 |
T201 |
for |
blockers,AT1R |
R330 |
T284 |
T201 |
for |
antagonists,AT1R |
R331 |
T289 |
T286 |
is_a |
proposed molecules,Losartan |
R332 |
T289 |
T285 |
is_a |
proposed molecules,Losartan |
R333 |
T293 |
T79 |
is_a |
peptide drugs,'counter-regulatory' |
R334 |
T293 |
T24 |
for |
peptide drugs,COVID-19 |
R335 |
T293 |
T194 |
coreference |
peptide drugs,Angiotensin 1-7 |
R336 |
T293 |
T249 |
coreference |
peptide drugs,Angiotensin 1-9 |
R337 |
T293 |
T250 |
coreference |
peptide drugs,Alamandine |
R338 |
T293 |
T253 |
coreference |
peptide drugs,Angiotensin A |
R339 |
T293 |
T165 |
coreference |
peptide drugs,Angiotensin IV |
R4 |
T36 |
T35 |
abbreviation |
RAS,'Renin-Angiotensin' System |
R41 |
T96 |
T97 |
has_status |
acute respiratory distress syndrome,lethal |
R42 |
T94 |
T87 |
cause_of |
hypovitaminosis D,cytokine storm |
R43 |
T94 |
T96 |
cause_of |
hypovitaminosis D,acute respiratory distress syndrome |
R44 |
T39 |
T87 |
cause_of |
RAS,cytokine storm |
R45 |
T39 |
T96 |
cause_of |
RAS,acute respiratory distress syndrome |
R48 |
T101 |
T110 |
abbreviation |
ACE2,Angiotensin-Converting Enzyme 2 |
R49 |
T3 |
T13 |
cause_of |
SARS-CoV-2,COVID-19 |
R5 |
T37 |
T62 |
abbreviation |
RAS,'Renin-Angiotensin' system |
R51 |
T100 |
T110 |
to |
interacting,Angiotensin-Converting Enzyme 2 |
R52 |
T98 |
T100 |
is_a |
spike (S) glycoprotein,interacting |
R53 |
T100 |
T123 |
is_a |
interacting,interfere |
R54 |
T123 |
T40 |
is_a |
interfere,RAS |
R55 |
T128 |
T126 |
- |
immune,macrophages |
R56 |
T114 |
T113 |
in |
blood vessels,epithelial cells |
R57 |
T115 |
T113 |
in |
lung,epithelial cells |
R58 |
T119 |
T113 |
in |
kidney,epithelial cells |
R59 |
T69 |
T113 |
in |
renal tubules,epithelial cells |
R6 |
T63 |
T25 |
is_a |
Counter-regulatory,'Renin-Angiotensin' System |
R60 |
T124 |
T113 |
in |
intestine,epithelial cells |
R61 |
T118 |
T113 |
in |
heart,epithelial cells |
R66 |
T4 |
T14 |
cause_of |
SARS-CoV-2,COVID-19 |
R7 |
T65 |
T62 |
synonym |
'Renin-Angiotensin-Aldosterone' system,'Renin-Angiotensin' system |
R83 |
T148 |
T41 |
is_a |
over-reaction,RAS |
R85 |
T15 |
T147 |
has_status |
COVID-19,diffuse |
R87 |
T149 |
T42 |
is_a |
imbalance,RAS |
R89 |
T149 |
T148 |
coreference |
imbalance,over-reaction |
R90 |
T121 |
T150 |
in |
kidney,Renin |
R91 |
T122 |
T151 |
in |
liver,Angiotensinogen |
R92 |
T150 |
T170 |
using |
Renin,cleaves |
R97 |
T174 |
T173 |
abbreviation |
ACE,Angiotensin-Converting Enzyme |